DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

被引：0
|
作者：
J Devon Roll
Ashley G Rivenbark
Wendell D Jones
William B Coleman
机构：
[1] University of North Carolina,Department of Pathology and Laboratory Medicine
[2] University of North Carolina,Department of Biochemistry and Biophysics
[3] University of North Carolina School of Medicine,UNC Lineberger Comprehensive Cancer Center
[4] Expression Analysis,undefined
来源：
Molecular Cancer | / 7卷
关键词：
Breast Cancer Cell Line; Human Breast Cancer Cell Line; MCF12A Cell; DNMT Activity; CDH1 Promoter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
    Risher, J. Devon
    Rivenbark, Ashley G.
    Jones, Wendell D.
    Coleman, William B.
    FASEB JOURNAL, 2008, 22
  • [2] DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
    Roll, J. Devon
    Rivenbark, Ashley G.
    Jones, Wendell D.
    Coleman, William B.
    MOLECULAR CANCER, 2008, 7 (1)
  • [3] RNAi-Mediated Knockdown of DNMT3b in Hypermethylator Breast Cancer Cell Lines Leads to Normalization of Gene Expression Patterns
    Roll, J. Devon
    Rinkenbaugh, Amanda L.
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    FASEB JOURNAL, 2009, 23
  • [4] Sensitization of Hypermethylator Breast Cancer Cells to Chemotherapy by Targeted and Pharmacologic Inhibition of DNMT3b
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    FASEB JOURNAL, 2011, 25
  • [5] Dysregulation of Multiple MicroRNAs Accompanies DNMT3b Overexpression and Expression of a Hypermethylation Defect in Breast Cancer Cell Lines
    Sandhu, Rupninder
    Coleman, William B.
    FASEB JOURNAL, 2010, 24
  • [6] Aberrant DNA methyltransferase 3b activity accounts for the hypermethylator phenotype in human breast cancer cell lines
    Risher, J. Devon
    Coleman, William B.
    FASEB JOURNAL, 2007, 21 (06): : A755 - A756
  • [7] Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 385 - 399
  • [8] Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
    Rupninder Sandhu
    Ashley G. Rivenbark
    William B. Coleman
    Breast Cancer Research and Treatment, 2012, 131 : 385 - 399
  • [9] A novel DNMT3B subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer
    Wang, Luo
    Wang, Jie
    Sun, Shiyong
    Rodriguez, Marivonne
    Yue, Ping
    Jang, Se Jin
    Mao, Li
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (01) : 201 - 207
  • [10] Oncogenic BRAFV600e Downregulates DNMT3B and Does Not Directly Induce the CpG Island Hypermethylator Phenotype in Human Colorectal
    MacKenzie, Douglas J.
    Robertson, Neil A.
    Cole, John
    Adams, Peter
    GASTROENTEROLOGY, 2015, 148 (04) : S570 - S570
12345